Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: The study of fat redistribution and metabolic change in HIV infection (FRAM)

American Journal of Nephrology

Volumn 33, Issue 5, 2011, Pages 453-460

  Jotwani, Vasantha ^a,b   Scherzer, Rebecca ^a,b   Choi, Andy ^a,b   Szczech, Lynda ^c   Polak, Joseph F ^d   Kronmal, Richard A ^e   Grunfeld, Carl ^a,b   Shlipak, Michael ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Cystatin C; HIV; Intima medial thickness; Kidney

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C;

ADULT; ALBUMINURIA; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY FAT DISTRIBUTION; COMMON CAROTID ARTERY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNAL CAROTID ARTERY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADIPOSE TISSUE; ADULT; ALBUMINURIA; ATHEROSCLEROSIS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79954606801     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000327606     Document Type: Article

References (25)

1. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S: Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr 2003;33:506-512. (Pubitemid 36886080)
2. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr: Carotidartery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22. (Pubitemid 29024679)
3. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML, Tien PC, Shlipak MG, Sidney S, Polak JF, O'Leary D, Bacchetti P, Kronmal RA: Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS 2009;23:1841-1849.
4. Humphreys MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 1995;48:311-320.
5. Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD: Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS 2004;18:541-546. (Pubitemid 38365883)
6. Szczech LA, Grunfeld G, Scherzer R, Canchola JA, van der Horst C, Sidney S, Wohl D, Shlipak MG: Microalbuminuria in HIV infection. AIDS 2007;21:1003-1009. (Pubitemid 46684331)
7. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM: The impact of HIV on chronic kidney disease outcomes. Kidney Int 2007;72:1380-1387. (Pubitemid 350126779)
8. Odden MC, Scherzer R, Bacchetti P, Szczech LA, Sidney S, Grunfeld G, Shlipak MG: Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 2007;167:2213-2219. (Pubitemid 350106741)
9. Choi AI, Scherzer R, Bacchetti P, Tien PC, Saag MS, Gibert C, Szczech LA, Grunfeld C, Shlipak MG: Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010;56:872-882.
10. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004;351:1296-1305.
11. Choi AI, Li Y, Deeks SG, Grunfeld C, Volberding PA, Shlipak MG: Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation 2010;121:651-658.
12. Tien PC, Benson C, Zolopa AR, Sidney S, Osmond D, Grunfeld C: The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics. Am J Epidemiol 2006;163:860-869.
13. Cockerham L, Scherzer R, Zolopa A, Rimland D, Lewis CE, Bacchetti P, Grunfeld C, Shlipak M, Tien PC: Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr 2010;53:102-106.
14. Erlandsen EJ, Randers E, Kristensen JH: Evaluation of the Dade Behring N Latex Cystatin C Assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest 1999;59:1-8. (Pubitemid 29133539)
15. Stevens LA, Coresh J, Schmid CH, et al: Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3, 418 individuals with CKD. Am J Kidney Dis 2008;51:395-406. (Pubitemid 351273480)
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
17. O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke 1991;22:1155-1163.
18. Zeger SL, Liang KY: Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130.
19. Schafer JL: Multiple imputation: a primer. Stat Methods Med Res 1999;8:3-15. (Pubitemid 29222784)
20. Robins JM, Finkelstein DM: Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) logrank tests. Biometrics 2000;56:779-788.
21. Searle SR, Speed FM, Milliken GA: Populations marginal means in the linear model: an alternative to least squares means. Am Statist 1980:216-221.
22. Bui AL, Katz R, Kestenbaum B, de Boer IH, Fried LF, Polak JF, Wasserman BA, Sarnak MJ, Siscovick D, Shlipak MG: Cystatin C and carotid intima-media thickness in asymptomatic adults: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2009;53:389-398.
23. Ix JH, Katz R, Kestenbaum B, Fried LF, Kramer H, Stehman-Breen C, Shlipak MG: Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol 2008;19:579-585. (Pubitemid 351355401)
24. Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JA, Siscovick D, Bertoni AG, Shlipak MG: Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2008;52:839-848.
25. Kramer H, Jacobs DR Jr, Bild D, Post W, Saad MF, Detrano R, Tracy R, Cooper R, Liu K: Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 2005;46:38-43. (Pubitemid 40946488)